TSE: 4506 - Sumitomo Pharma Co., Ltd.

Yield per half year: +68.73%
Sector: Healthcare

Sumitomo Pharma Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
12.14 111.03 -89.06% 15.51 -21.68%
P/S 0.5103 75.03 -99.32%
P/BV 1.03 70.29 -98.54%
P/FCF -1.02 80.52 -101.27%
Ev/Ebitda -1.74 76.71 -102.27%
Ev/S 1.75 72.43 -97.58%
Ev/FCF -2.14 15.5 -113.79%
E/P -1.2 0.1179 -1117.74%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-100.59 -78.2 28.63% -7.49 +1 242.74%
ROE -201.82 -10.46 1830.31%
ROA -34.71 -10.03 245.99%
ROIC -9.57 9.09 -205.29%
ROS -100.13 -143.89 -30.41%
ROCE -226.85 2.34 -9778.96%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-1.32 1.08 -222.78% -18.3 -92.77%
Nеt Debt/Ebitda -1.23 -0.3908 215.21%
Debt/Ratio 0.4616 0.1308 252.8%
Debt/Equity 7.11 6.92 2.73%
Debt/Net Income -1.33 -1.84 -27.78%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 2.62 -100% 2.47 -100%
Number of years of dividend growth 0 1.16 -100%
DSI 0.6429 0.7238 -11.19%
Average dividend growth -16.57 -10.93 51.62%
Average percentage for 5 years 2.47 1.88 30.94%
Average percentage for payments 23.96 37.94 -36.84%
Difference from average difference in sector -2.62

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-34.84 170.19 -120.47%
Growth impulse Ebitda in 5 years -403.76 101.21 -498.93%
Growth impulse Net Income in 5 years -872.93 82.55 -1157.46%
Growth impulse FCF in 5 years -885.92 104.08 -951.19%
Growth impulse EPS in 5 years -872.85 127.91 -782.39%
IP Score
3.49/10

Similar companies

Eisai Co., Ltd.

COSMOS Pharmaceutical Corporation

Astellas Pharma Inc.

Welcia Holdings Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription